Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
35.25 GBX | -1.54% | -0.70% | +38.24% |
Apr. 10 | Futura Medical hails results as erectile dysfunction drug drives sales | AN |
Apr. 10 | Transcript : Futura Medical plc, 2023 Earnings Call, Apr 10, 2024 |
Sales 2023 | 3.1M 3.88M | Sales 2024 * | 9.69M 12.11M | Capitalization | 108M 135M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | 22.3 x |
Net cash position 2023 | 7.71M 9.64M | Net cash position 2024 * | 3.21M 4.01M | EV / Sales 2024 * | 10.8 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 12 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 67.12% |
Latest transcript on Futura Medical plc
1 day | +0.90% | ||
1 week | +1.75% | ||
Current month | -10.81% | ||
1 month | -5.56% | ||
3 months | +19.21% | ||
6 months | +12.53% | ||
Current year | +41.65% |
Managers | Title | Age | Since |
---|---|---|---|
James Barder
CEO | Chief Executive Officer | - | 01-05-31 |
Angela Hildreth
DFI | Director of Finance/CFO | - | 18-02-19 |
Ken James
CTO | Chief Tech/Sci/R&D Officer | - | 16-03-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Needham
CHM | Chairman | 68 | 21-10-07 |
Gordon Davis
BRD | Director/Board Member | 67 | Jan. 08 |
James Barder
CEO | Chief Executive Officer | - | 01-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 35.25 | -1.54% | 205 782 |
24-04-24 | 35.8 | +0.70% | 253,853 |
24-04-23 | 35.55 | -0.14% | 350,597 |
24-04-22 | 35.6 | -0.14% | 204,772 |
24-04-19 | 35.65 | +0.42% | 425,707 |
Delayed Quote London S.E., April 25, 2024 at 03:46 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+41.65% | 134M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.16% | 22.2B | |
-16.53% | 21.23B | |
-8.72% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- FUM Stock